Igor Petrovich Bobrov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Igor Petrovich Bobrov has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Yu. Dolgatov
Altai State Medical University
19 shared publications A.V. Lepilov
12 shared publications- Aleksandr Yurievich Zharikov
Алтайский государственный медицинский университет
12 shared publications E.S. Dolgatova
12 shared publicationsN.A. Korsikov
12 shared publications- Olesya Nikolayevna Mazko
Altai State Medical University, Barnaul
11 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (2) , 30-37
EFFECT OF COMBINED ADMINISTRATION OF THE TRIPEPTIDE LEU-ILE-LYS AND INDOMETHACIN ON THE GASTRIC MUCOSA IN AN EXPERIMENT
Introduction. Non-steroidal anti-inflammatory drugs represent a commonly prescribed category of pharmacologically active agents. A notable adverse effect associated with these medications is their potential to induce ulcers. Previously, researchers at Altai State Medical University developed a tripeptide, Leu-Ile-Lys, which exhibited an anti-ulcer effect in experimental settings following 7 days of administration prior to the induction of indomethacin-induced gastropathy. To comprehensively evaluate the preclinical characteristics of this tripeptide, it is essential to investigate its efficacy when administered concurrently with indomethacin. Objective. The aim of this study is to examine the impact of the simultaneous administration of the Leu-Ile-Lys tripeptide and indomethacin on the gastric mucosa in experimental conditions. Materials and Methods. The study involved 24 Wistar rats, which were allocated into a control group, an experimental group, and a comparison group. All subjects received intragastric indomethacin (6.3 mg/kg) for a duration of 7 days. In the experimental group, indomethacin was co-administered with 11.5 mg/kg of the tripeptide, while the comparison group received omeprazole (37 mg/kg). A pathomorphological examination of the stomachs of the experimental rats was performed to assess the extent of mucosal injury, the density and composition of the inflammatory infiltrate, and the level of DNA accumulation. Results. Following the 7-day co-administration of both the Leu-Ile-Lys tripeptide and omeprazole alongside indomethacin, no erosive or ulcerative damage to the gastric mucosa was observed, in contrast to the control group. The thickness of the gastric mucosa in the experimental group was significantly greater, exceeding that of the control group by a factor of 2.2 and the comparison group by a factor of 1.6. The proportion of degranular type cells in the experimental group was statistically significantly reduced compared to the control group by a factor of 2.4, and compared to the comparison group by a factor of 1.2. The DNA accumulation index observed in the experimental group exceeded that of the control group by a factor of 1.2, and was greater than that of the comparison group by a factor of 1.1. Conclusion. The simultaneous administration of the Leu-Ile-Lys tripeptide alongside indomethacin in laboratory rats mitigated the ulcerogenic effects associated with indomethacin, which was accompanied by a proliferative response.
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (2) , 30-37
Open AccessEFFECT OF COMBINED ADMINISTRATION OF THE TRIPEPTIDE LEU-ILE-LYS AND INDOMETHACIN ON THE GASTRIC MUCOSA IN AN EXPERIMENT
Introduction. Non-steroidal anti-inflammatory drugs represent a commonly prescribed category of pharmacologically active agents. A notable adverse effect associated with these medications is their potential to induce ulcers. Previously, researchers at Altai State Medical University developed a tripeptide, Leu-Ile-Lys, which exhibited an anti-ulcer effect in experimental settings following 7 days of administration prior to the induction of indomethacin-induced gastropathy. To comprehensively evaluate the preclinical characteristics of this tripeptide, it is essential to investigate its efficacy when administered concurrently with indomethacin. Objective. The aim of this study is to examine the impact of the simultaneous administration of the Leu-Ile-Lys tripeptide and indomethacin on the gastric mucosa in experimental conditions. Materials and Methods. The study involved 24 Wistar rats, which were allocated into a control group, an experimental group, and a comparison group. All subjects received intragastric indomethacin (6.3 mg/kg) for a duration of 7 days. In the experimental group, indomethacin was co-administered with 11.5 mg/kg of the tripeptide, while the comparison group received omeprazole (37 mg/kg). A pathomorphological examination of the stomachs of the experimental rats was performed to assess the extent of mucosal injury, the density and composition of the inflammatory infiltrate, and the level of DNA accumulation. Results. Following the 7-day co-administration of both the Leu-Ile-Lys tripeptide and omeprazole alongside indomethacin, no erosive or ulcerative damage to the gastric mucosa was observed, in contrast to the control group. The thickness of the gastric mucosa in the experimental group was significantly greater, exceeding that of the control group by a factor of 2.2 and the comparison group by a factor of 1.6. The proportion of degranular type cells in the experimental group was statistically significantly reduced compared to the control group by a factor of 2.4, and compared to the comparison group by a factor of 1.2. The DNA accumulation index observed in the experimental group exceeded that of the control group by a factor of 1.2, and was greater than that of the comparison group by a factor of 1.1. Conclusion. The simultaneous administration of the Leu-Ile-Lys tripeptide alongside indomethacin in laboratory rats mitigated the ulcerogenic effects associated with indomethacin, which was accompanied by a proliferative response.
- 25 October 2025
- Published by ECO-Vector LLC (Publications) in Russian Journal of Oncology
- Vol. 30 (4) , 312-322
Nucleolus, ribosome biogenesis, and tumor growth: a review
This review addresses the relationship between the structural changes and functional activity of the nucleolus, and ribosome biogenesis in the initiation and progression of cancer. To prepare this review, an electronic systematic search of review and original research articles was conducted in the PubMed database, focusing on studies of the nucleolar apparatus in tumor growth. The literature search was performed in English using the following key terms: nucleolus, nucleolar stress, ribosome biogenesis, and cancer. The mechanisms underlying nucleolar stress and the molecular pathways leading to nucleolar apparatus dysfunction during tumorigenesis are discussed. It is shown that nucleolar dysfunction and accelerated ribosome biogenesis result from mutations and alterations in the expression of tumor suppressors, oncogenes, and cell cycle regulators. An increase in the number and size of nucleoli is identified as an important prognostic factor in cancers. Dysregulation of nucleolar function and structural alterations of ribosomes play a substantial role in cancer pathogenesis in the context of ribosomopathies and viral diseases. Investigation into the molecular mechanisms underlying nucleolar abnormalities, ribosome biogenesis, and ribosomal dysfunction may facilitate the development of novel targeted anticancer therapies.
- 25 October 2025
- Published by ECO-Vector LLC (Publications) in Russian Journal of Oncology
- Vol. 30 (4) , 312-322
Nucleolus, ribosome biogenesis, and tumor growth: a review
This review addresses the relationship between the structural changes and functional activity of the nucleolus, and ribosome biogenesis in the initiation and progression of cancer. To prepare this review, an electronic systematic search of review and original research articles was conducted in the PubMed database, focusing on studies of the nucleolar apparatus in tumor growth. The literature search was performed in English using the following key terms: nucleolus, nucleolar stress, ribosome biogenesis, and cancer. The mechanisms underlying nucleolar stress and the molecular pathways leading to nucleolar apparatus dysfunction during tumorigenesis are discussed. It is shown that nucleolar dysfunction and accelerated ribosome biogenesis result from mutations and alterations in the expression of tumor suppressors, oncogenes, and cell cycle regulators. An increase in the number and size of nucleoli is identified as an important prognostic factor in cancers. Dysregulation of nucleolar function and structural alterations of ribosomes play a substantial role in cancer pathogenesis in the context of ribosomopathies and viral diseases. Investigation into the molecular mechanisms underlying nucleolar abnormalities, ribosome biogenesis, and ribosomal dysfunction may facilitate the development of novel targeted anticancer therapies.
- 2 September 2025
- Published by Folium Publishing Company in Экспериментальная и клиническая фармакология
- Vol. 88 (8) , 19-22
Изучение токсичности трипептида Leu-Ile-Lys при однократном введении грызунам
Проведено изучение токсичности трипептида Leu-Ile-Lys при однократном внутрижелудочном введении в дозе 2000 мг/кг мышам и крысам (самцы и самки поровну). Введение Leu-Ile-Lys мышам и крысам в дозе 2000 мг/кг не вызвало гибели животных, а также проявлений токсичности. Масса тела экспериментальных животных не имела статистически значимых межгрупповых различий. При патоморфологическом исследовании внутренних органов каких-либо патологических изменений обнаружено не было. Таким образом, трипептид Leu-Ile-Lys относится к IV классу опасности (малоопасные вещества). Полученные данные свидетельствуют о перспективе клинического применения указанного соединения.
- 2 September 2025
- Published by Folium Publishing Company in Экспериментальная и клиническая фармакология
- Vol. 88 (8) , 19-22
Изучение токсичности трипептида Leu-Ile-Lys при однократном введении грызунам
Проведено изучение токсичности трипептида Leu-Ile-Lys при однократном внутрижелудочном введении в дозе 2000 мг/кг мышам и крысам (самцы и самки поровну). Введение Leu-Ile-Lys мышам и крысам в дозе 2000 мг/кг не вызвало гибели животных, а также проявлений токсичности. Масса тела экспериментальных животных не имела статистически значимых межгрупповых различий. При патоморфологическом исследовании внутренних органов каких-либо патологических изменений обнаружено не было. Таким образом, трипептид Leu-Ile-Lys относится к IV классу опасности (малоопасные вещества). Полученные данные свидетельствуют о перспективе клинического применения указанного соединения.
- 31 March 2025
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 3_2025, 213-218
Ovarian torsion in the first stage of term labor
- 31 March 2025
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 3_2025, 213-218
Ovarian torsion in the first stage of term labor
- Open Access
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (4) , 66-74
MODULATORY EFFECTS OF PLANT-DERIVED FORMULATIONS ON EXPERIMENTAL URATE NEPHROLITHIASIS PROGRESSION
Introduction. Urate nephrolithiasis is a common form of urolithiasis that is prone to recurrence, making the development of new pharmacological agents for the prevention of this condition an important scientific task. In this regard, biogenic agents that combine high efficacy with low side effects are traditionally of great interest. Altai State Medical University has developed three compositions with potential antiliogenic properties that require experimental validation. Objective. Testing of compositions in experimental urate nephrolithiasis. Materials and Methods. Male Wistar rats were used as a biological system. Urate nephrolithiasis was modeled for 3 weeks by administering uric and oxonic acids. Three compositions were administered orally at a dose of 101 mg/kg (days 11-21 of the study). The urine was analyzed for the activity of lactate dehydrogenase, γ-glutamyltranspeptidase, and their ratios. A pathomorphological study of the kidneys was performed to determine the number of cases of nephrolithiasis, the histological picture of the renal tissue, and the number and area of urate deposits. Result. When using the composition of natural origin 1 and 2, nephrolithiasis was detected in 30% of the cases, while it was detected in 10% of the cases when using the composition of natural origin 3, compared to 67% in the control group. At the end of the experiment, the ratio of lactate dehydrogenase activity to γ-glutamyltranspeptidase activity in the urine was significantly reduced by 4.2 times when using the composition of natural origin-3 compared to the control group. Conclusion. Thus, it was revealed that the natural origin compositions introduction of all the studied leads to a decrease in the course of experimental urate nephrolithiasis, which is most pronounced when the natural-origin composition-3 is introduced.
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (4) , 66-74
Open AccessMODULATORY EFFECTS OF PLANT-DERIVED FORMULATIONS ON EXPERIMENTAL URATE NEPHROLITHIASIS PROGRESSION
Introduction. Urate nephrolithiasis is a common form of urolithiasis that is prone to recurrence, making the development of new pharmacological agents for the prevention of this condition an important scientific task. In this regard, biogenic agents that combine high efficacy with low side effects are traditionally of great interest. Altai State Medical University has developed three compositions with potential antiliogenic properties that require experimental validation. Objective. Testing of compositions in experimental urate nephrolithiasis. Materials and Methods. Male Wistar rats were used as a biological system. Urate nephrolithiasis was modeled for 3 weeks by administering uric and oxonic acids. Three compositions were administered orally at a dose of 101 mg/kg (days 11-21 of the study). The urine was analyzed for the activity of lactate dehydrogenase, γ-glutamyltranspeptidase, and their ratios. A pathomorphological study of the kidneys was performed to determine the number of cases of nephrolithiasis, the histological picture of the renal tissue, and the number and area of urate deposits. Result. When using the composition of natural origin 1 and 2, nephrolithiasis was detected in 30% of the cases, while it was detected in 10% of the cases when using the composition of natural origin 3, compared to 67% in the control group. At the end of the experiment, the ratio of lactate dehydrogenase activity to γ-glutamyltranspeptidase activity in the urine was significantly reduced by 4.2 times when using the composition of natural origin-3 compared to the control group. Conclusion. Thus, it was revealed that the natural origin compositions introduction of all the studied leads to a decrease in the course of experimental urate nephrolithiasis, which is most pronounced when the natural-origin composition-3 is introduced.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (4)
Effect of the tripeptide Leu-Ile-Lys on the gastric mucosa in an experiment
Introduction. The high prevalence of gastric ulcer, as well as its multiple etiologies substantiate the urgency of developing new drugs effective in this condition. Previously, the antiulcer effect of the tripeptide Leu-Ile-Lys (LK-3) was revealed under experimental conditions in gastropathies of various origins. To clarify the mechanism of action of this compound, an in-depth experimental study of its effects on the gastric mucosa (GM) is necessary. Aim. To study the effect of the tripeptide LK-3 on GM under experimental conditions. Materials and methods. The experiment was performed on 16 Wistar rats. All animals were divided into two groups: the intact group and the group with intragastric administration of the tripeptide LK-3 (for 7 days, 11,5 mg/kg). Pathomorphological examination of the stomachs of experimental rats was performed. A histological picture of the GM was examined, and its thickness was measured. In addition, the density and composition of the inflammatory infiltrate, as well as the DNA replication index in the nuclei of cervical GM cells were determined. Results. During gross and microscopic examination, no pathological changes in the GM were revealed in either experimental group. The tripeptide LK-3 administration caused a statistically significant increase in GM thickness, by 1,4 times, compared to the intact group. In addition, the DNA replication ratio in cervical GM cells in rats treated with LK-3 was 1,2 times higher than in intact animals. At the same time, 100% of the cells studied were in the S-phase of the cell cycle after administration of LK-3, compared to 75% in the intact group. Conclusion. A 7-day intragastric administration of the tripeptide LK-3 (11,5 mg/kg) to rats caused an increase in GM thickness and in the proportion of cells in the S-phase of the cell cycle.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (4)
Effect of the tripeptide Leu-Ile-Lys on the gastric mucosa in an experiment
Introduction. The high prevalence of gastric ulcer, as well as its multiple etiologies substantiate the urgency of developing new drugs effective in this condition. Previously, the antiulcer effect of the tripeptide Leu-Ile-Lys (LK-3) was revealed under experimental conditions in gastropathies of various origins. To clarify the mechanism of action of this compound, an in-depth experimental study of its effects on the gastric mucosa (GM) is necessary. Aim. To study the effect of the tripeptide LK-3 on GM under experimental conditions. Materials and methods. The experiment was performed on 16 Wistar rats. All animals were divided into two groups: the intact group and the group with intragastric administration of the tripeptide LK-3 (for 7 days, 11,5 mg/kg). Pathomorphological examination of the stomachs of experimental rats was performed. A histological picture of the GM was examined, and its thickness was measured. In addition, the density and composition of the inflammatory infiltrate, as well as the DNA replication index in the nuclei of cervical GM cells were determined. Results. During gross and microscopic examination, no pathological changes in the GM were revealed in either experimental group. The tripeptide LK-3 administration caused a statistically significant increase in GM thickness, by 1,4 times, compared to the intact group. In addition, the DNA replication ratio in cervical GM cells in rats treated with LK-3 was 1,2 times higher than in intact animals. At the same time, 100% of the cells studied were in the S-phase of the cell cycle after administration of LK-3, compared to 75% in the intact group. Conclusion. A 7-day intragastric administration of the tripeptide LK-3 (11,5 mg/kg) to rats caused an increase in GM thickness and in the proportion of cells in the S-phase of the cell cycle.
- Open Access
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 28-34
EFFECT OF LEU-ILE-LYS TRIPEPTIDE ON EXPERIMENTAL HISTAMINE-INDUCED GASTROPATHY
Introduction. The high prevalence of gastric ulcer, a polyethological disease formed due to increased hydrochloric acid and/or violation of protective properties of the gastric mucosa, determines the urgency of developing new drugs with an anticarcinogenic effect. According to the results of research conducted at the Altai State Medical University, the tripeptide Leu-Ile-Lys was obtained, which was successfully tested under experimental conditions against the background of gastropathies caused by the administration of drugs that directly or indirectly reduce the protective properties of the gastric mucosa. In the next stage of the preclinical study of the anti-ulcer properties of this compound, it is necessary to test it against the background of gastropathy induced by the administration of histamine, a substance that stimulates the gastric secretion of hydrochloric acid. Objective. To study the effect of the Leu-Ile-Lys tripeptide on the course of experimental histamine-induced gastropathy. Materials and Methods. Stock Wistar rats were used as a biological model for the study. The animals were divided into the control group, the Leu-Ile-Lys tripeptide administration group (11.5 mg/kg) and the omeprazole comparison drug administration group (37 mg/kg). These substances were administered intragastrically for 7 days. Histamine-induced gastropathy was simulated in animals of all groups. Subsequently, the stomachs of experimental rats were extracted to study the pathomorphological signs of the pathology. Results. When histamine-induced gastropathy in the control group, broad surface erosions of the gastric mucosa were revealed, as well as dystrophy and necrobiosis of the integumentary pit epithelium with the development of lymphoplasmocytic infiltration. Against this background, with the administration of Leu-Ile-Lys tripeptide and omeprazole, the morphological picture of the gastric mucosa was close to normal. In the Leu-Ile-Lys tripeptide group, the thickness of the gastric mucosa increased statistically significantly by 1.1 times relative to the control, while in the indicator omeprazole group, the value studied indicator was statistically significantly lower than in the Leu-Ile-Lys tripeptide group by 1.3 times, and in untreated rats by 1.2 times. Conclusion. Thus, the Leu-Ile-Lys tripeptide demonstrated an anti-ulcerative effect against the background of histamine-induced gastropathy, which was accompanied by an increase in the thickness of the gastric mucosa relative to disease control and the omeprazole administration group.
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 28-34
Open AccessEFFECT OF LEU-ILE-LYS TRIPEPTIDE ON EXPERIMENTAL HISTAMINE-INDUCED GASTROPATHY
Introduction. The high prevalence of gastric ulcer, a polyethological disease formed due to increased hydrochloric acid and/or violation of protective properties of the gastric mucosa, determines the urgency of developing new drugs with an anticarcinogenic effect. According to the results of research conducted at the Altai State Medical University, the tripeptide Leu-Ile-Lys was obtained, which was successfully tested under experimental conditions against the background of gastropathies caused by the administration of drugs that directly or indirectly reduce the protective properties of the gastric mucosa. In the next stage of the preclinical study of the anti-ulcer properties of this compound, it is necessary to test it against the background of gastropathy induced by the administration of histamine, a substance that stimulates the gastric secretion of hydrochloric acid. Objective. To study the effect of the Leu-Ile-Lys tripeptide on the course of experimental histamine-induced gastropathy. Materials and Methods. Stock Wistar rats were used as a biological model for the study. The animals were divided into the control group, the Leu-Ile-Lys tripeptide administration group (11.5 mg/kg) and the omeprazole comparison drug administration group (37 mg/kg). These substances were administered intragastrically for 7 days. Histamine-induced gastropathy was simulated in animals of all groups. Subsequently, the stomachs of experimental rats were extracted to study the pathomorphological signs of the pathology. Results. When histamine-induced gastropathy in the control group, broad surface erosions of the gastric mucosa were revealed, as well as dystrophy and necrobiosis of the integumentary pit epithelium with the development of lymphoplasmocytic infiltration. Against this background, with the administration of Leu-Ile-Lys tripeptide and omeprazole, the morphological picture of the gastric mucosa was close to normal. In the Leu-Ile-Lys tripeptide group, the thickness of the gastric mucosa increased statistically significantly by 1.1 times relative to the control, while in the indicator omeprazole group, the value studied indicator was statistically significantly lower than in the Leu-Ile-Lys tripeptide group by 1.3 times, and in untreated rats by 1.2 times. Conclusion. Thus, the Leu-Ile-Lys tripeptide demonstrated an anti-ulcerative effect against the background of histamine-induced gastropathy, which was accompanied by an increase in the thickness of the gastric mucosa relative to disease control and the omeprazole administration group.
- Open Access
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №3 2025,p. 13
QUANTITATIVE ANALYSIS OF CD4+ LYMPHOCYTE CONTENT IN THE PERITUMOUR ZONE OF LUMINAL RENAL CELL CARCINOMA
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №3 2025,p. 13
Open AccessQUANTITATIVE ANALYSIS OF CD4+ LYMPHOCYTE CONTENT IN THE PERITUMOUR ZONE OF LUMINAL RENAL CELL CARCINOMA
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (1) , 52-59
EVALUATION OF THE EFFICACY OF LEU-ILE-LYS TRIPEPTIDE IN THE CONTEXT OF CHRONIC ACETATE-INDUCED GASTROPATHY
Introduction. Peptic ulcer is a common multifactorial disease that significantly reduces the quality of life of a large number of patients. An obligatory stage in the development of new methods of pharmacological correction of this pathology is their experimental testing on models of acute and chronic gastropathy. Previously, studies were conducted on the basis of the Altai State Medical University, which demonstrated the Leu-Ile-Lys antiulcer effect of the tripeptide on models of acute gastropathy: indomethacin, ethanol and predniolone. For a complete preclinical assessment of the test substance, it is necessary to test it under conditions of modeling chronic gastric ulceration modeling. Objective. Study of the effect of Leu-Ile-Lys tripeptide on the course of experimental chronic "acetate" gastropathy. Materials and methods. The experiments were carried out on stock Wistar rats, divided into a disease control group, a treatment group that received Leu-Ile-Lys tripeptide at a dose of 11.5 mg / kg and a comparison group administered omeprazole at a dose of 37 mg/kg. In all groups, chronic acetate gastropathy was simulated, followed by intragastric administration of the studied substances for 5 days. At the end of the experiment, the stomachs of the experimental animals were extracted, revealing macro- and microscopic signs of the development of the pathological process. Results. The size of ulcerative defects compared to the same indicator of the disease control group was significantly decreased by 2.5 times in rats treated with the Leu-Ile-Lys tripeptide, while against the background of omeprazole administration it decreased by 1.7 times. According to the results of a pathohistological study in the Leu-Ile-Lys tripeptide treatment group, a decrease in inflammatory infiltration was recorded in the area of ulcerative defects, an increase in the number of collagen fibers and an increase in angiogenesis processes relative to the disease control groups and the administration of omeprazole. Conclusion. Thus, during the experimental testing of the Leu-Ile-Lys tripeptide against the background of chronic "acetate" gastropathy, the presence of an antiulcer effect of the substance under study was revealed, which is characterized by a decrease in the size of ulcerative defects, as well as activation of regeneration processes.
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (1) , 52-59
EVALUATION OF THE EFFICACY OF LEU-ILE-LYS TRIPEPTIDE IN THE CONTEXT OF CHRONIC ACETATE-INDUCED GASTROPATHY
Introduction. Peptic ulcer is a common multifactorial disease that significantly reduces the quality of life of a large number of patients. An obligatory stage in the development of new methods of pharmacological correction of this pathology is their experimental testing on models of acute and chronic gastropathy. Previously, studies were conducted on the basis of the Altai State Medical University, which demonstrated the Leu-Ile-Lys antiulcer effect of the tripeptide on models of acute gastropathy: indomethacin, ethanol and predniolone. For a complete preclinical assessment of the test substance, it is necessary to test it under conditions of modeling chronic gastric ulceration modeling. Objective. Study of the effect of Leu-Ile-Lys tripeptide on the course of experimental chronic "acetate" gastropathy. Materials and methods. The experiments were carried out on stock Wistar rats, divided into a disease control group, a treatment group that received Leu-Ile-Lys tripeptide at a dose of 11.5 mg / kg and a comparison group administered omeprazole at a dose of 37 mg/kg. In all groups, chronic acetate gastropathy was simulated, followed by intragastric administration of the studied substances for 5 days. At the end of the experiment, the stomachs of the experimental animals were extracted, revealing macro- and microscopic signs of the development of the pathological process. Results. The size of ulcerative defects compared to the same indicator of the disease control group was significantly decreased by 2.5 times in rats treated with the Leu-Ile-Lys tripeptide, while against the background of omeprazole administration it decreased by 1.7 times. According to the results of a pathohistological study in the Leu-Ile-Lys tripeptide treatment group, a decrease in inflammatory infiltration was recorded in the area of ulcerative defects, an increase in the number of collagen fibers and an increase in angiogenesis processes relative to the disease control groups and the administration of omeprazole. Conclusion. Thus, during the experimental testing of the Leu-Ile-Lys tripeptide against the background of chronic "acetate" gastropathy, the presence of an antiulcer effect of the substance under study was revealed, which is characterized by a decrease in the size of ulcerative defects, as well as activation of regeneration processes.
- Open Access
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №1 2025,p. 71
PROGNOSTIC VALUE OF THE STUDY OF INFLAMMATORY INFILTRATE IN THE PERITUMOR ZONE OF MALIGNANT NEOPLASMS (LITERATURE REVIEW)
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №1 2025,p. 71
Open AccessPROGNOSTIC VALUE OF THE STUDY OF INFLAMMATORY INFILTRATE IN THE PERITUMOR ZONE OF MALIGNANT NEOPLASMS (LITERATURE REVIEW)